Krishna Institute of Medical Sciences (KIMS) investor relations material

Executive summary

• Q1 FY26 consolidated revenue reached INR 879 crores (₹8,716 million), up 26.8% YoY and 9.6% QoQ, with EBITDA at INR 200 crores, up 8.5% YoY but down 1.4% QoQ.

• PAT stood at INR 85 crores (₹786 million), down from INR 95 crores YoY and INR 106 crores QoQ; EPS at INR 1.96, down 9.2% YoY.

• Celebrated Silver Jubilee with 25 centers, 8,000 beds, and 20,000+ workforce, with ongoing expansion and technology-driven care.

• ARPOB and ARPP grew 11.8% and 9.8% YoY, with IP and OP volumes up 15.3% and 19.3% YoY.

• Unaudited results for Q1 FY26 were approved by the Board, with auditors issuing an unmodified opinion.

Financial highlights

• Total revenue for Q1 FY26 at INR 879 crores (₹8,716 million), up 26.8% YoY and 9.6% QoQ.

• EBITDA at INR 200 crores, up 8.5% YoY but down 1.4% QoQ; EBITDA margin at 22.7% versus 26.6% last year.

• PAT at INR 85 crores (₹786 million), down from INR 95 crores YoY and INR 106 crores QoQ; EPS at INR 1.96, down 9.2% YoY.

• Net debt as of June 30, 2025, stands at INR 2,020 crores; cash and equivalents at INR 70 crores.

• Standalone revenue for Q1 FY26 was ₹3,734 million, up from ₹3,274 million YoY; standalone net profit was ₹588 million.

Outlook and guidance

• EBITDA margin guidance for FY26 in the 22–25% range.

• New units expected to reach EBITDA breakeven within 12 months of full operations.

• Company ARPU expected to grow 4–5% annually, with potential to reach INR 50,000–55,000 as new high-ARPU units ramp up.

• Losses from new units expected to neutralize by Q2 FY27, with no further greenfield drag until FY29.

• Expansion plans include new hospitals and departments in Bangalore, Ongole, Anantapur, Kondapur, and Rajahmundry, with phased openings from Q2 FY26 to Q4 FY27.